Raymond James Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
Raymond James Financial's RYTM Position: Q3 2026 in Review
Raymond James Financial reduced its Rhythm Pharmaceuticals (RYTM) stake by 61% in Q3 2026, selling an estimated $3.81M and leaving 22,408 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3469.
Raymond James Financial first reported a position in RYTM in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.45M in Q2 2026. 239 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Raymond James Financial held 22,408 shares of Rhythm Pharmaceuticals worth $2.13M as of Q3 2026.
- Raymond James Financial sold 35,661 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $3.81M.
- Rhythm Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #3469 holding.
- Raymond James Financial first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- Raymond James Financial's Rhythm Pharmaceuticals position peaked at $6.45M in Q2 2026.
- 239 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.